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influences the intracellular accumulation of tacrolimus 
in HEK293 and K562 recombinant cell lines. PLoS One. 
2014 Mar 12;9(3):e91555. The authors apologize to the 
Editors and readers, as well as to the authors of the origi-
nal article.
The Editors-in-Chief of Cancer Chemotherapy & Phar-
macology have decided to retract this article. Substantial 
portions of this article were found to have been published 
previously by: G. Dessilly, L. Elens, N. Panin, A. Capron, 
A. Decottignies, JB Demoulin V. Haufroid, ABCB1 
1199G (2014) A genetic polymorphism (Rs2229109) 
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